Diabetes, Vol 43, Issue 1 33-39, Copyright © 1994 by American Diabetes Association
Isolation of nonobese diabetic mouse T-cells that recognize novel autoantigens involved in the early events of diabetes
C Gelber, L Paborsky, S Singer, D McAteer, R Tisch, C Jolicoeur, R Buelow, H McDevitt and CG Fathman
ImmuLogic Pharmaceutical, Palo-Alto, CA 94304.
Insulin-dependent diabetes mellitus (IDDM) is thought to result from
chronic, cell-mediated, autoimmune islet damage. Our aim was to identify
the earliest T-cell autoantigen in IDDM, reasoning that this antigen could
be causally involved in the initiation of the disease. Identification of
the earliest beta-cell-specific autoantigen is extremely important in
allowing advances in prevention and treatment of initial events in the
development of inflammatory insulitis that precedes beta-cell destruction
and overt diabetes. Therefore, we analyzed the proliferative responses of
peripheral T-cells from young, female nonobese diabetic (NOD) mice to
extracts of pancreatic beta-cell lines. We were able to demonstrate that
T-cells responsive to beta-cell antigens exist in the peripheral lymphoid
tissue of these mice in the absence of deliberate priming before the
manifestation of histologically detectable insulitis. T-cell lines and
clones isolated from the peripheral lymphatic tissues of young,
unimmunized, female NOD mice were also shown to react with extracts of
beta-cells. Fractionation of the beta-cell extracts showed that these
T-cell clones recognized multiple beta-cell-specific autoantigens but none
of the previously reported putative autoantigens (glutamic acid
decarboxylase [GAD]65, GAD67, Hsp65, insulin, ICA 69, carboxypeptidase-H,
and peripherin). Thus, we can conclude that these responses are specific
for novel beta-cell autoantigens. Finally, NOD T-cell proliferative
responses were also seen to an extract of human islets suggesting potential
shared antigenic determinants between human and mouse beta-cells.(ABSTRACT
TRUNCATED AT 250 WORDS)